Almost the same, the expression level of TNF-α in AD-MSC- and AD-CM-treated groups was decreased with superiority for the AD-CM-treated group, in which the TNF-α expression level was more similar to the control group. The gene discussed is TNF; the disease is Alzheimer disease.